Free Trial
ASX:BDA

Bod Australia (BDA) Stock Price, News & Analysis

About Bod Australia Stock (ASX:BDA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
75,095 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bod Australia Limited operates as a cannabis centric healthcare company in Australia, the United Kingdom, and internationally. The company operates through three segments: Medical, OTC CBD/Hemp, and OTC Herbals. It offers medicinal cannabis, cannabidiol (CBD), and hemp healthcare products. The company has a collaboration agreement with Drug Science UK to assess the efficacy of its medicinal cannabis, MediCabilis in managing symptoms associated with the long term impact of SARS-CoV-2. Bod Australia Limited was incorporated in 2014 and is based in Double Bay, Australia.

Receive BDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bod Australia and its competitors with MarketBeat's FREE daily newsletter.

BDA Stock News Headlines

Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
UK logs another SEVENTY-SEVEN monkeypox cases
Will Bod Australia (ASX:BOD) Spend Its Cash Wisely?
BOD Australia Ltd (BDA)
See More Headlines

BDA Stock Analysis - Frequently Asked Questions

Bod Australia Limited (ASX:BDA) posted its earnings results on Thursday, February, 28th. The company reported ($0.05) EPS for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bod Australia investors own include Queensland Pacific Metals (QPM), Argent BioPharma (MXC), Medlab Clinical (MDC), Lynas Rare Earths (LYC), iSignthis (ISX), Imugene (IMU) and Eclipx Group (ECX).

Company Calendar

Last Earnings
2/28/2019
Today
5/25/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Household & Personal Products
Sub-Industry
N/A
Current Symbol
ASX:BDA
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.42 million
Price / Cash Flow
3.54
Book Value
A$0.08 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (ASX:BDA) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners